A combinatorial delivery of survivin targeted siRNA using cancer selective nanoparticles for triple negative breast cancer therapy

[1]  P. Kesharwani,et al.  Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer. , 2022, Colloids and surfaces. B, Biointerfaces.

[2]  P. Kesharwani,et al.  Potential of particle size less than 15 nm via olfactory region for direct brain delivery via Intranasal route , 2022, Health Sciences Review.

[3]  P. Kesharwani,et al.  Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics. , 2022, International journal of pharmaceutics.

[4]  Saleh A. Ahmed,et al.  Journey of anthraquinones as anticancer agents – a systematic review of recent literature , 2021, RSC advances.

[5]  P. Kesharwani,et al.  RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[6]  Y. Bustanji,et al.  Fabrication of aptamer-guided siRNA loaded lipopolyplexes for gene silencing of notch 1 in MDA-mb-231 triple negative breast cancer cell line , 2021 .

[7]  P. Kesharwani,et al.  Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery , 2021 .

[8]  P. Kesharwani,et al.  An insight into aptamer engineered dendrimer for cancer therapy , 2021, European Polymer Journal.

[9]  Saurabh Sharma,et al.  Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment. , 2021, Materials science & engineering. C, Materials for biological applications.

[10]  P. Kesharwani,et al.  Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer. , 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  Xing Tang,et al.  Fabricating nanoparticles co-loaded with survivin siRNA and Pt(IV) prodrug for the treatment of platinum-resistant lung cancer. , 2021, International journal of pharmaceutics.

[12]  Xue Li,et al.  Doxorubicin-Loaded Metal-Organic Frameworks Nanoparticles with Engineered Cyclodextrin Coatings: Insights on Drug Location by Solid State NMR Spectroscopy , 2021, Nanomaterials.

[13]  S. Pal,et al.  Nano-MOFs as targeted drug delivery agents to combat antibiotic-resistant bacterial infections , 2020, Royal Society Open Science.

[14]  Liqing Chen,et al.  Enhancing anti-melanoma outcomes in mice using novel chitooligosaccharide nanoparticles loaded with therapeutic survivin-targeted siRNA. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  S. M. Taghdisi,et al.  Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells. , 2020, Carbohydrate polymers.

[16]  Melissa Johnson,et al.  Lycopene in human health , 2020, LWT.

[17]  Xiaoxuan Liu,et al.  Self-assembly of amphiphilic phospholipid peptide dendrimer-based nanovectors for effective delivery of siRNA therapeutics in prostate cancer therapy. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Shubiao Zhang,et al.  Co-delivery of paclitaxel and survivin siRNA with cationic liposome for lung cancer therapy , 2020 .

[19]  Michael R Hamblin,et al.  Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells. , 2019, Colloids and surfaces. B, Biointerfaces.

[20]  Charis M. Galanakis,et al.  A facile water-induced complexation of lycopene and pectin from pink guava byproduct: Extraction, characterization and kinetic studies. , 2019, Food chemistry.

[21]  M. Ramezani,et al.  Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells, in vitro and in vivo evaluation , 2019, Drug development and industrial pharmacy.

[22]  A. Kamal,et al.  Multicomponent access to novel proline/cyclized cysteine tethered monastrol conjugates as potential anticancer agents , 2019, Journal of Saudi Chemical Society.

[23]  L. Du,et al.  Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy. , 2019, Acta biomaterialia.

[24]  Moganavelli Singh,et al.  Dendrimer functionalized folate-targeted gold nanoparticles for luciferase gene silencing in vitro: A proof of principle study , 2018, Acta pharmaceutica.

[25]  Cui Tang,et al.  Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. , 2018, Biomaterials.

[26]  A. Pourjavadi,et al.  Codelivery of Hydrophobic and Hydrophilic Drugs by Graphene-Decorated Magnetic Dendrimers. , 2018, Langmuir : the ACS journal of surfaces and colloids.

[27]  Michael R Hamblin,et al.  PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. , 2018, Applied materials today.

[28]  T. Minko,et al.  Metastatic and triple-negative breast cancer: challenges and treatment options , 2018, Drug Delivery and Translational Research.

[29]  O. Pinho,et al.  Can lycopene be considered an effective protection against cardiovascular disease? , 2018, Food chemistry.

[30]  I. Banerjee,et al.  Photo-triggered destabilization of nanoscopic vehicles by dihydroindolizine for enhanced anticancer drug delivery in cervical carcinoma. , 2018, Colloids and surfaces. B, Biointerfaces.

[31]  Keerti Jain,et al.  Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery. , 2017, Drug discovery today.

[32]  Ji Pu,et al.  GABAB receptor ligand-directed trimethyl chitosan/tripolyphosphate nanoparticles and their pMDI formulation for survivin siRNA pulmonary delivery. , 2018, Carbohydrate polymers.

[33]  D. Young,et al.  Inclusion complexation of catechin by β-cyclodextrins: Characterization and storage stability , 2017 .

[34]  Zhigui Su,et al.  Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis. , 2017, International journal of pharmaceutics.

[35]  Q. Xiong,et al.  A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma. , 2017, Colloids and surfaces. B, Biointerfaces.

[36]  K. Khairou,et al.  Pd nanoparticles supported on iron oxide nanorods for CO oxidation: Effect of preparation method , 2016 .

[37]  R. Jamal,et al.  Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors. , 2016, Molecular pharmaceutics.

[38]  Fanzhu Li,et al.  A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[39]  Sanjeev Banerjee,et al.  Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. , 2015, Colloids and surfaces. B, Biointerfaces.

[40]  Sanjeev Banerjee,et al.  PAMAM dendrimers as promising nanocarriers for RNAi therapeutics , 2015 .

[41]  R. Tyagi,et al.  Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. , 2015, Colloids and surfaces. B, Biointerfaces.

[42]  Sanjeev Banerjee,et al.  Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells. , 2015, Biomacromolecules.

[43]  J. Nah,et al.  Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Xiangliang Yang,et al.  Codelivery of doxorubicin and curcumin with lipid nanoparticles results in improved efficacy of chemotherapy in liver cancer , 2014, International journal of nanomedicine.

[45]  R. Tekade,et al.  Generation Dependent Safety and Efficacy of Folic Acid Conjugated Dendrimer Based Anticancer Drug Formulations , 2015, Pharmaceutical Research.

[46]  Chao Chen,et al.  Targeted delivery of Dicer-substrate siRNAs using a dual targeting peptide decorated dendrimer delivery system. , 2014, Nanomedicine : nanotechnology, biology, and medicine.

[47]  Keerti Jain,et al.  Dendrimer as nanocarrier for drug delivery , 2014 .

[48]  C. Kitamura,et al.  Characterization and thermal isomerization of (all-E)-lycopene. , 2014, Journal of agricultural and food chemistry.

[49]  Minghui Zhang,et al.  Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients , 2014, Targeted Oncology.

[50]  Y. Oh,et al.  Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA. , 2011, Biomaterials.

[51]  J. Erdman,et al.  Lycopene and apo-10'-lycopenal do not alter DNA methylation of GSTP1 in LNCaP cells. , 2011, Biochemical and biophysical research communications.

[52]  Xing-Jie Liang,et al.  Theranostic nanoparticles engineered for clinic and pharmaceutics. , 2011, Accounts of chemical research.

[53]  S. Simões,et al.  Survivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agents. , 2011, Molecular pharmaceutics.

[54]  D. Bahadur,et al.  Dendrimer–Doxorubicin conjugate for enhanced therapeutic effects for cancer , 2011 .

[55]  L. Rodriguez-Saona,et al.  External calibration models for the measurement of tomato carotenoids by infrared spectroscopy , 2011 .

[56]  G. P. Agrawal,et al.  Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[57]  S. Nguyen,et al.  Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy. , 2010, Journal of the American Chemical Society.

[58]  Huibi Xu,et al.  Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[59]  G. Russo,et al.  Phytochemicals in Cancer Prevention and Therapy: Truth or Dare? , 2010, Toxins.

[60]  C. M. Roth,et al.  PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma. , 2009, Bioconjugate chemistry.

[61]  V. Böhm,et al.  Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. , 2009, Molecular nutrition & food research.

[62]  T. Minko,et al.  Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. , 2009, Biomacromolecules.

[63]  C. Szabó,et al.  Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. , 2007, American journal of physiology. Heart and circulatory physiology.

[64]  R. V. van Breemen,et al.  Multitargeted therapy of cancer by lycopene. , 2008, Cancer letters.

[65]  A. Rosenberg,et al.  Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients , 2007, Cancer.

[66]  Joy Joseph,et al.  Doxorubicin-induced apoptosis: Implications in cardiotoxicity , 2002, Molecular and Cellular Biochemistry.

[67]  L. O’Driscoll,et al.  Prognostic importance of survivin in breast cancer , 2003, British Journal of Cancer.